Trial Condition(s):

Stroke, Acute Ischemic Stroke

Repinotan in Patients with Acute Ischemic Stroke

Bayer Identifier:

100282

ClinicalTrials.gov Identifier:

NCT00044915

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this trial is to evaluate Repinotan HCl in patients with acute ischemic stroke. At study entry patients will be randomized to Repinotan HCl or placebo in a 1:1 ratio. The total treatment period wil be 72 hours.

Inclusion Criteria
- Acute ischemic stroke of hemispheric localization (exclude brainstem and cerebellum), of suspected thromboembolic origin.  - Males or females aged 18 years or over.  - National Institute of Health Stroke Scale (NIH-SS) total score 8 to 23 with a motor deficit >/= 2 (for either one arm or leg) and level of consciousness < 2 and at least one of the following: Visual field deficit, neglect, or aphasia. If a patient receives t-PA, NIH-SS must be performed prior to receiving the study drug but after infusion of t-PA is initiated.  - Signed informed consent from patient or legally authorized representative
Exclusion Criteria
- CT scan evidence of:  - Clearly defined areas of hypodensity indicating infarction of >1/3 of the MCA territory or evidence of significant mass effect with shift of midline or major areas of sulcal effacement associated with loss of cortical definition (grey-white distinction).  Minor early CT changes are common in MCA strokes and patients with early or subtle changes are eligible.  - A primary intra-cerebral haemorrhage or any finding not consistent with an acute ischemic stroke as the cause of presenting symptoms.  - Clinical evidence of acute stroke due to lacunar infarct (pure motor hemiplegia; pure sensory deficit, ataxia/clumsy hand syndromes)- Neurological (other than the presenting stroke) or psychiatric conditions that may affect the patient's functional status and/or that may interfere with the patient's assessment- Clinically relevant pre-existing neurological deficit (Historical Rankin score >/= 2 regardless of cause)- Generalized seizures having developed since the onset of stroke symptoms- Systolic blood pressure > 210 or < 110 mmHg (confirmed by up to three readings prior to randomization)- Diastolic blood pressure > 110 or < 60 mmHg (confirmed by up to three readings prior to randomization)- Myocardial infarction within 3 months,  unstable angina within 3-5 days prior to starting infusion, unstable supra-ventricular and/or ventricular arrhythmia, severe conduction defect (AV block grades 2 and 3), complete left or right Bundle Branch Block, bradycardia (heart rate [HR] less than 50 bpm), uncompensated heart failure- History of myocarditis, cardiomyopathy or aortic stenosis- Patients known to have prolonged QTc intervals (inherited and sporadic syndromes of QTc prolongation or QTc interval > 450 msec males and 470 msec females on baseline ECG) or using Class IA or Class III antiarrhythmic drugs (e.g., quinidine, procainamide, amiodarone, sotalol)- Any patients that require initiation of new digoxin therapy are excluded.  Patients already on digoxin therapy (for at least 1 month stable dose) at time of enrollment will be allowed in the study.- Electrolyte imbalance at baseline.  Should the results not be available before starting the study drug infusion, the patients will be allowed in the study providing that the corrective therapy of any abnormal electrolyte results is implemented immediately upon availability of the laboratory report.- Any conditions predisposing to electrolyte imbalances (e.g., chronic vomiting, anorexia nervosa, bulimia nervosa) will also be excluded at baseline.- Participation in a research protocol for investigation of a pharmaceutical agent or innovative invasive procedure (including intra-arterial t-PA) within the past 30 days- Previously in the BRAIN-Study or treated with repinotan- Life expectancy of less than 6 months due to comorbid conditions- Any other known clinically significant medical disorder (e.g., cardiovascular, gastrointestinal, hepatic, renal, endocrine, major uncompensated metabolic disturbances, respiratory, immunological, hematological or bleeding disorder, cancer, AIDS)

Trial Summary

Enrollment Goal
782
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
Yes
Products
Repinotan (BAYX3702)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Locations
Locations

Royal Melbourne Hospital

Melbourne, Australia, 3052

Locations

Hôpital Pellegrin Tripode - Bordeaux

BORDEAUX, France, 33000

Locations

Ninewells Hospital

Dundee, United Kingdom, DD2 1UB

Locations

Chaim Sheba Medical Center

Tel Hashomer, Israel, 52621

Locations

Universitair Medisch Centrum Groningen

GRONINGEN, Netherlands, 9713 GZ

Locations

Gosford Hospital

Gosford, Australia, 2250

Locations

Sint-Jozefkliniek

BORNEM, Belgium, 2880

Locations

Klinikum Minden

Minden, Germany, 32427

Locations

Hospital del Mar

Barcelona, Spain, 08003

Locations

Mikkelin keskussairaala

Mikkeli, Finland, FIN-50100

Locations

Southern General Hospital

Glasgow, United Kingdom, G51 4TG

Locations

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel, 64239

Locations

A.O.U. Policlinico Umberto I

Roma, Italy, 00155

Locations

Donauklinikum- Standort Gugging

Klosterneuburg, Austria, 3400

Locations

Hospital Clínico Universitario de Santiago de Compostela

Santiago de Compostela, Spain, 15706

Locations

Borsod County Hospital

Miskolc, Hungary, 3526

Locations

Universitätsklinikum Charite zu Berlin

Berlin, Germany, 10117

Locations

HUS, Meilahden sairaala

Helsinki, Finland, 00290

Locations

IRCCS Ist Neurologico Mondino

Pavia, Italy, 27100

Locations

Karolinska University Hospital

Stockholm, Sweden, 171 76

Locations

Landes-Nervenklinik Wagner-Jauregg Linz

Linz, Austria, 4020

Locations

Austin Repatriation Medical Centre, Austin Campus

Melbourne, Australia, 3084

Locations

Universität Leipzig

Leipzig, Germany, 04103

Locations

Päijät-Hämeen keskussairaala

Lahti, Finland, 15850

Locations

Hôpital Pasteur - Nice

NICE, France, 06200

Locations

Western Galille Hospital Nahariya

Nahariya, Israel, 22100

Locations

Krankenhaus der Barmherzigen Brüder

Wien, Austria, 1021

Locations

Ciutat Sanitària i Universitaria de la Vall d'Hebrón

Barcelona, Spain, 08035

Locations

John Hunter Hospital

New Lambton Heights, Australia, 2305

Locations

Klinikum Großhadern der Ludwig-Maximilians-Universität

München, Germany, 81377

Locations

Universitair Medisch Centrum St. Radboud

NIJMEGEN, Netherlands, 6525 GA

Locations

AULSS 06 Vicenza - Veneto

Vicenza, Italy, 36100

Locations

Norrlands Universitetssjukhus

Umeå, Sweden, 901 85

Locations

CU Saint-Luc/UZ St-Luc

BRUXELLES - BRUSSEL, Belgium, 1200

Locations

Kuopion yliopistollinen sairaala

Kuopio, Finland, 70120

Locations

Leicester Royal Infirmary

Leicester, United Kingdom, LE1 5WW

Locations

Edith Wolfson Medical Center

Holon, Israel, 58100

Locations

Ospedale Borgo Trento

Verona, Italy, 37126

Locations

Bnai Zion Medical Center

Haifa, Israel, 31048

Locations

A.O. di Reggio Emilia

Reggio Emilia, Italy, 42100

Locations

Ocala Neurodiagnostic Center

Ocala, United States, 34471

Locations

Klinikum der Eberhard-Karls-Universität Tübingen

Tübingen, Germany, 72076

Locations

Royal Hobart Hospital

Hobart, Australia, 7000

Locations

Rambam Medical Center

Haifa, Israel, 31096

Locations

Policlinico Monteluce

Perugia, Italy, 06126

Locations

Western Medical Centre

Melbourne, Australia, 3011

Locations

Klinikum der Universität Regensburg

Regensburg, Germany, 93053

Locations

The Alfred Hospital

Melbourne, Australia, 3181

Locations

Städ. Krankenhaus München-Harlaching

München, Germany, 81545

Locations

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Spain, 50009

Locations

Rabin Medical Center, Campus Golda

Petach Tikva, Israel, 49372

Locations

A.O. Osp San Carlo Borromeo

Milano, Italy, 20153

Locations

Office of Dr. Rodney D. Bell, MD

Philadelphia, United States, 19107

Locations

AUSL 4 L'Aquila - Abruzzo

L'Aquila, Italy, 67100

Locations

Universitätsklinikum Heidelberg

Heidelberg, Germany, 69120

Locations

Hospital Clínico Universitario de Valencia

Valencia, Spain, 46010

Locations

Friedrich-Alexander-Universität Erlangen-Nürnberg

Erlangen, Germany, 91054

Locations

Hospital Universitario "La Paz"

Madrid, Spain, 28046

Locations

ASL 8 Vibo Valentia - Calabria

Vibo Valentia, Italy, 89900

Locations

Advanced Neurology Specialists

Great Falls, United States, 59405

Locations

Medizinische Einrichtungen der Universität Essen

Essen, Germany, 45147

Locations

Forsyth Medical Center

Winston-Salem, United States, 27103

Locations

Universitätsklinikum Münster

Münster, Germany, 48149

Locations

North County Neurology Associates

Oceanside, United States, 92056-4405

Locations

University of California-San Diego Medical Center

San Diego, United States, 92103-8765

Locations

Klinikum der Johann Wolfgang Goethe Universität

Frankfurt, Germany, 60596

Locations

Kliniken und Polikliniken der Albert-Ludwigs-Universität

Freiburg, Germany, 79106

Locations

Westpfalz-Klinikum GmbH

Kaiserslautern, Germany, 67655

Locations

The Queen's Medical Center

Honolulu, United States, 96813-2413

Locations

MetroHealth Medical Center

Cleveland, United States, 44109-1998

Locations

University of North Carolina

Chapel Hill, United States, 27599-7065

Locations

Crozer-Chester Medical Center

Upland, United States, 19013-3995

Locations

Office of Dr. Harmeet Sachdev, MD

San Jose, United States, 95124

Locations

UCLA Emergency Medical Center

Los Angeles, United States, 90024-1777

Locations

North Memorial Health Care

Robbinsdale, United States, 55422-2900

Locations

Dekalb Medical Center

Decatur, United States, 30033

Locations

Overlake Hospital Medical Center

Bellevue, United States, 98004-4687

Locations

Foothills Medical Centre

Calgary, Canada, T2N 2T9

Locations

Ottawa Hospital-General Campus

Ottawa, Canada, K1H 8L6

Locations

Queen Elizabeth II Health Sciences Centre

Halifax, Canada, B3H 3A7

Locations

Trilium Health Centre

Mississauga, Canada, L5B 1B8

Locations

Toronto Western Hospital-University Health Network

Toronto, Canada, M5T 2S8

Locations

Hopital Charles LeMoyne

Greenfield Park, Canada, J4V 2H1

Locations

Royal University Hospital

Saskatoon, Canada, S7N 0W8

Locations

Center for Neurological Research

Lethbridge, Canada, T1KOC9

Locations

Penticton Regional Hospital

Penticton, Canada, V2A 3G6

Locations

St. Boniface General Hospital

Winnipeg, Canada, R2H 2A6

Locations

The Barzilai Medical Center Ashkelon

Ashkelon, Israel, 78306

Locations

Mercy Ruan Neurology Clinic

Des Moines, United States, 50314

Locations

Gold Coast Hospital

Southport, Australia, 4215

Locations

A.O. Sant' Anna

Como, Italy, 22100

Locations

Long Island Jewish Medical Center

New Hyde Park, United States, 11040-1496

Locations

Medizinische Einrichtungen der Universität zu Köln

Köln, Germany, 50931

Locations

Florida Neurovascular Institute

Tampa, United States, 33606

Locations

Universitätsklinikum Otto-von Guericke - Magdeburg

Magdeburg, Germany, 39112

Locations

Klinikum der Ernst-Moritz-Arndt-Universität

Greifswald, Germany, 17489

Locations

Rhön-Klinikum AG

Bad Neustadt, Germany, 97616

Locations

Vivantes Klinikum im Friedrichshain

Berlin, Germany, 10249

Locations

Klinikum der Universität Würzburg

Würzburg, Germany, 97080

Locations

Valley Hospital

Ridgewood, United States, 07450

Locations

Kliniken Nord und Süd

Nürnberg, Germany, 90419

Locations

Baylor College of Medicine

Houston, United States, 77030

Locations

Johns Hopkins University School of Medicine

Baltimore, United States, 21224

Locations

Klinikum Aschaffenburg

Aschaffenburg, Germany, 63739

Locations

Providence St.Vincent Medical Center

Portland, United States, 97225

Locations

Coastal Neurology, PA

Beaufort, United States, 29902-5472

Locations

Brain Matters, Inc.

Boynton Beach, United States, 33435-6000

Locations

Neurologic Consultants, PA

Ft. Lauderdale, United States, 33308

Locations

Solaris Health System/JFK Medical Center

Edison, United States, 08818-3903

Locations

Erlanger Medical Center

Chattanooga, United States, 37403-2112

Locations

SUNY University Hospital/Health Science Center

Stony Brook, United States, 11794

Locations

London Health Sciences Centre

London, Canada, N6A 5A5

Locations

Office of Dr. Donald A. Cameron, MD

North Vancouver, Canada, V7L 2L3

Locations

University of Alberta

Edmonton, Canada, T6G 2B7

Locations

Hopital de L'Enfant Jesus

Quebec City, Canada, G1J 1Z4

Locations

Vancouver Hospital/Health Science Center

Vancouver, Canada, V5Z 1M9

Locations

Victoria General Hospital - Victoria

Victoria, Canada, V8Z 6R5

Locations

Complexe Hospitalier de la Sagamie

Chicoutimi, Canada, G7H 5H6

Locations

St. John Regional Hospital

St. John, Canada, E2L 4L2

For details, please refer to trial results

Additional Information